Literature DB >> 33297435

Getting Lost in the Cell-Lysosomal Entrapment of Chemotherapeutics.

Xingjian Zhai1, Yassine El Hiani1.   

Abstract

Despite extensive research, resistance to chemotherapy still poses a major obstacle in clinical oncology. An exciting strategy to circumvent chemoresistance involves the identification and subsequent disruption of cellular processes that are aberrantly altered in oncogenic states. Upon chemotherapeutic challenges, lysosomes are deemed to be essential mediators that enable cellular adaptation to stress conditions. Therefore, lysosomes potentially hold the key to disarming the fundamental mechanisms of chemoresistance. This review explores modes of action of classical chemotherapeutic agents, adaptive response of the lysosomes to cell stress, and presents physiological and pharmacological insights pertaining to drug compartmentalization, sequestration, and extracellular clearance through the lens of lysosomes.

Entities:  

Keywords:  cancer therapy; chemoresistance; chemotherapeutics; lysosomal entrapment; lysosomes

Year:  2020        PMID: 33297435      PMCID: PMC7762281          DOI: 10.3390/cancers12123669

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  130 in total

1.  Solving the secretory acid sphingomyelinase puzzle: Insights from lysosome-mediated parasite invasion and plasma membrane repair.

Authors:  Norma W Andrews
Journal:  Cell Microbiol       Date:  2019-06-10       Impact factor: 3.715

2.  Second malignancies associated with doxorubicin.

Authors:  J Blatt
Journal:  Pediatr Hematol Oncol       Date:  1995 Mar-Apr       Impact factor: 1.969

3.  Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform.

Authors:  I Wessel; L H Jensen; P B Jensen; J Falck; A Rose; M Roerth; J L Nitiss; M Sehested
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

4.  Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial. Danish Society of Haematology Study Group on AML.

Authors:  P de Nully Brown; T Hoffmann; O P Hansen; A M Boesen; K Grønbaek; E Hippe; M K Jensen; K Thorling; H H Storm; J Pedersen-Bjergaard
Journal:  Leukemia       Date:  1997-01       Impact factor: 11.528

Review 5.  Chemistry and chemical biology of taxane anticancer agents.

Authors:  M L Miller; I Ojima
Journal:  Chem Rec       Date:  2001       Impact factor: 6.771

6.  The VPS34 PI3K negatively regulates RAB-5 during endosome maturation.

Authors:  Fiona Law; Jung Hwa Seo; Ziqing Wang; Jennifer L DeLeon; Yousstina Bolis; Ashley Brown; Wei-Xing Zong; Guangwei Du; Christian E Rocheleau
Journal:  J Cell Sci       Date:  2017-04-28       Impact factor: 5.285

7.  Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin.

Authors:  Hartmut Derendorf
Journal:  Int J Antimicrob Agents       Date:  2020-05-07       Impact factor: 5.283

8.  Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity.

Authors:  Benny Zhitomirsky; Anna Yunaev; Roman Kreiserman; Ariel Kaplan; Michal Stark; Yehuda G Assaraf
Journal:  Cell Death Dis       Date:  2018-12-13       Impact factor: 8.469

9.  Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer.

Authors:  Iris C Salaroglio; Elena Gazzano; Ahmad Abdullrahman; Eleonora Mungo; Barbara Castella; Gamal Eldein Fathy Abd-Ellatef Abd-Elrahman; Massimo Massaia; Massimo Donadelli; Menachem Rubinstein; Chiara Riganti; Joanna Kopecka
Journal:  J Exp Clin Cancer Res       Date:  2018-11-27

10.  ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer.

Authors:  Franklin C Harwood; Ramon I Klein Geltink; Brendan P O'Hara; Monica Cardone; Laura Janke; David Finkelstein; Igor Entin; Leena Paul; Peter J Houghton; Gerard C Grosveld
Journal:  Sci Adv       Date:  2018-09-12       Impact factor: 14.136

View more
  1 in total

Review 1.  Lysosomes and Cancer Progression: A Malignant Liaison.

Authors:  Eda R Machado; Ida Annunziata; Diantha van de Vlekkert; Gerard C Grosveld; Alessandra d'Azzo
Journal:  Front Cell Dev Biol       Date:  2021-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.